ASH 2024: Global Updates in the Management of Chronic Lymphocytic Leukemia - Episode 1
Recent Guideline Updates in the Frontline Management of CLL
Carsten Niemann, MD, PhD, Arnon Kater, MD, PhD, Othman Al-Sawaf, MD, John F. Seymour, MBBS, FRACP, PhD Dr Niemann provides an overview of the evolving treatment landscape of CLL.
Video content above is prompted by the following:
- Provide a brief review of the evolving treatment landscape for newly diagnosed CLL.
- Available therapy options (time-limited vs continuous).
- Preference for targeted therapy approaches over conventional chemotherapy.
- Key challenges and unmet needs in the 1L setting.